Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
BMC Infectious Diseases|October 24, 2023
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19B Cosmi, M Giannella, G Fornaro, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study GroupV Joly, M Moroni, E Concia, et al.
Oncotarget|August 3, 2013
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1Alexander Gont, Jennifer E L Hanson, Sylvie J Lavictoire, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Infection|May 30, 2009
Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapyA Antinori, A Ammassari, C Torti, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
Infection|June 15, 2007
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006)G Carosi, E Quiros-Roldan, C Torti, et al.
AIDS Research and Human Retroviruses|December 16, 2000
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infectionM Floridia, C Tomino, R Bucciardini, et al.
Pageof 23